Dhanuka Agritech Limited

BSE:507717 Stock Report

Market Cap: ₹51.9b

Dhanuka Agritech Future Growth

Future criteria checks 2/6

Dhanuka Agritech is forecast to grow earnings and revenue by 10.5% and 11.5% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

10.5%

Earnings growth rate

10.17%

EPS growth rate

Chemicals earnings growth19.4%
Revenue growth rate11.5%
Future return on equity17.16%
Analyst coverage

Good

Last updated21 May 2026

Recent future growth updates

Recent updates

Narrative Update • May 03

507717: Upcoming Director Appointment Will Support Future Upside Confidence

Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).
Narrative Update • Apr 18

507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence

Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).
Narrative Update • Apr 03

507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence

Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).
Narrative Update • Mar 19

507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential

Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).
Narrative Update • Mar 05

507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential

Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
New Narrative • Feb 21

Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?
Narrative Update • Feb 19

507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential

Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
New Narrative • Feb 06

Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?
Narrative Update • Feb 04

507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.
Narrative Update • Jan 21

507717: Higher Margin Outlook Will Support Long-Term Upside Potential

Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.
Narrative Update • Jan 06

507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).
Narrative Update • Dec 16

507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential

Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.
Narrative Update • Dec 02

507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum

Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).
Narrative Update • Nov 17

507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion

Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.
Narrative Update • Nov 03

507717: New Nagpur Plant And Higher Margins Will Drive Future Upside

Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.
Narrative Update • Sep 05

Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand

With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
User avatar
New Narrative • Feb 09

Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets

International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.

Earnings and Revenue Growth Forecasts

BSE:507717 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202825,9563,5382,5333,1726
3/31/202722,9913,0651,9692,7524
3/31/202620,6282,8721,6851,962N/A
12/31/202519,7852,650N/AN/AN/A
9/30/202520,1382,8007142,663N/A
6/30/202520,6993,036N/AN/AN/A
3/31/202520,3522,9706872,627N/A
12/31/202419,6142,805N/AN/AN/A
9/30/202419,1942,7089851,431N/A
6/30/202418,8312,550N/AN/AN/A
3/31/202417,5852,3914511,345N/A
12/31/202317,6152,454N/AN/AN/A
9/30/202317,5162,4611,0612,317N/A
6/30/202316,7662,173N/AN/AN/A
3/31/202317,0022,3351201,362N/A
12/31/202216,4732,226N/AN/AN/A
9/30/202216,1082,191-640331N/A
6/30/202215,0672,094N/AN/AN/A
3/31/202214,7782,0894451,043N/A
12/31/202114,3502,031N/AN/AN/A
9/30/202113,7382,0077921,038N/A
6/30/202113,7742,074N/AN/AN/A
3/31/202113,8752,1062,1842,311N/A
12/31/202013,3952,009N/AN/AN/A
9/30/202013,1531,8862,5892,726N/A
6/30/202012,7491,785N/AN/AN/A
3/31/202011,2011,4131,4841,621N/A
12/31/201910,8521,291N/AN/AN/A
9/30/201910,3051,160N/A627N/A
6/30/201910,1181,111N/AN/AN/A
3/31/201910,0581,126N/A133N/A
12/31/20189,9821,145N/AN/AN/A
9/30/201810,0291,285N/AN/AN/A
6/30/20189,6761,262N/AN/AN/A
3/31/20189,6261,262N/A1,377N/A
12/31/20179,2651,201N/AN/AN/A
9/30/20179,1681,183N/AN/AN/A
6/30/20178,8121,156N/AN/AN/A
3/31/20178,8331,219N/A631N/A
12/31/20168,8861,237N/AN/AN/A
9/30/20168,8571,196N/AN/AN/A
6/30/20168,4691,081N/AN/AN/A
3/31/20168,2891,073N/A1,397N/A
12/31/20158,1161,007N/AN/AN/A
9/30/20157,8501,002N/AN/AN/A
6/30/20157,9771,042N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 507717's forecast earnings growth (10.5% per year) is above the savings rate (6.9%).

Earnings vs Market: 507717's earnings (10.5% per year) are forecast to grow slower than the Indian market (16.4% per year).

High Growth Earnings: 507717's earnings are forecast to grow, but not significantly.

Revenue vs Market: 507717's revenue (11.5% per year) is forecast to grow faster than the Indian market (10.8% per year).

High Growth Revenue: 507717's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 507717's Return on Equity is forecast to be low in 3 years time (17.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/21 11:24
End of Day Share Price 2026/05/21 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dhanuka Agritech Limited is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
null nullAntique Stockbroking Ltd.